Get the free weekly contract digest
The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
New new contracts, summarized for you
No login, no app to check — it comes to you
See who's moving and how much in your market
Senseera Raises $7.1 Million Seed Round Led by Lightspeed Venture Partners for Advancing Innovative Liquid Biopsy Platform
Contract Type
partnership
JerusalemBiotechnologyHealth CareDescription
Senseera has successfully closed a $7.1 million seed funding round led by Lightspeed Venture Partners, with the participation from I-Next Capital and the Lowy Medical Research Institute. The funding will be used to advance Senseera's GEM BIOMARKERS™ liquid biopsy platform, which aims to provide detailed molecular insights for diagnosing and monitoring diseases, particularly focusing on liver diseases management. This funding will also support the acceleration of market entry of Senseera's next-generation transplant rejection test, advance clinical trials, and expand partnerships with global biopharma.